Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
about
Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model systemProgress and problems with the use of suicide genes for targeted cancer therapyA conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effectExperimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.Molecular-genetic imaging of cancer.Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.PAX3 and FOXD3 Promote CXCR4 Expression in MelanomaTargeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenovirusesCD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer.Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational controlLow-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cellsConditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.Production and organization of neocortical interneurons.Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Targeting Melanoma with Cancer-Killing Viruses.Construction and Quantitative Validation of Chicken CXCR4 Expression Reporter.Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.Enhanced efficiency and specificity of ovarian cancer gene therapy in rats with a novel nonviral gene delivery system (GE7) via intraovarian artery perfusion approach.Evaluation of tumor-specific promoter activities in melanoma.Exploiting the Intron-splicing Mechanism of Insect Cells to Produce Viral Vectors Harboring Toxic Genes for Suicide Gene Therapy.Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.
P2860
Q25257352-E61441EE-B31F-466B-8FC8-C86E835D8299Q28262370-B9AA7F79-5FDF-404D-9401-156FD909111AQ34008026-5CFAEBF1-D59F-40A5-8FC1-E0E81770A0F2Q34148975-CF21D3A3-1918-4A96-9EC7-E96933A68F69Q35116121-5A3D6360-4905-43CE-B5EB-FE607AD6E1FDQ35754085-506D9492-7041-497B-97C7-3C4F527255A0Q35889581-4617F833-63D0-4085-BD57-906F619F3B5CQ36065213-45490A5D-9D2A-4173-AD7F-8F54D060DAECQ36387918-6A39414A-7701-40EF-BBEA-73C72B9637B1Q36406924-E2174EA0-F8E8-47FC-AAA0-469CAB573482Q36498617-C5F1D6E1-6449-47CF-AC7C-2E08C4270119Q36909502-E8B6E17A-01B4-4529-B9B4-090EF4796B39Q37277441-11C4EE9F-059E-4E60-84AB-761A2FC8B7FFQ37331001-00FBEDBB-6A82-4E6A-890E-EB933646E7BCQ37448942-9B1BC7B7-CAB1-4B31-9D88-88F3DCCBCB92Q37629088-389C4455-473A-4F63-A896-44712912BB95Q38676416-2262AEC2-C108-4CC6-80E1-8C7902641E62Q38799530-30734E92-3424-4FDE-97DF-9D8CB056CD5EQ40203638-937CE83B-5572-479D-AC94-4E2D07339AD2Q40419668-B22DFF6C-03BA-4BBB-B703-5D8262729500Q40461124-E4F45B65-D61B-42FF-89AB-86FC6CD491CCQ41879420-F3D54E4E-39F1-45B2-9E33-35C69D70774FQ45868822-0C4FE7EF-9ECA-4E30-A720-6272834E9C21
P2860
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
@en
type
label
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
@en
prefLabel
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
@en
P2093
P2860
P356
P1433
P1476
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
@en
P2093
Alvarez RD
Kaliberova L
Leath CA 3rd
Mahasreshti PJ
Makhija SK
Nettelbeck DM
P2860
P2888
P304
P356
10.1038/SJ.GT.3302089
P577
2004-04-01T00:00:00Z
P5875
P6179
1016184895